Article
MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
La Clinica terapeutica - 1 Jan 2000
Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo G M, Balacco Gabrieli C
Abstract excerpt
OBJECTIVE: To determine whether methylene tetrahydrofolate reductase (MTHFR) C677T mutation, factor II G20210A mutation and factor V Leiden are risk factors for retinal vein occlusion (RVO) in patients under fifty years of age. METHODS: Comparison of 29 patients, under 50 years old of age, as affected RVO and 62 age matched normal controls. Plasma MTHFR C677T genotype, Factor II G20210A genotype, Factor V Leiden...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.